investorscraft@gmail.com

Intrinsic ValueTohoku Chemical Co., Ltd. (7446.T)

Previous Close¥3,880.00
Intrinsic Value
Upside potential
Previous Close
¥3,880.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Tohoku Chemical Co., Ltd. operates as a specialized trading company in Japan, focusing on the distribution of chemicals, reagents, and related equipment across multiple industries. Its core revenue streams stem from pesticides, food additives, industrial chemicals, and clinical diagnostic reagents, catering to agriculture, healthcare, and manufacturing sectors. The company serves as a critical intermediary, supplying high-purity reagents and analytical tools for research, medical diagnostics, and industrial applications. Tohoku Chemical has established a niche presence by integrating distribution with technical support, ensuring reliability for clients in regulated industries. Its diversified product portfolio, spanning agricultural materials, medical devices, and hygiene products, positions it as a versatile supplier in Japan’s specialty chemicals market. While not a dominant player, its regional focus and long-standing relationships with manufacturers and end-users provide stability in a competitive landscape. The company’s involvement in cultivation and sale of flowers, alongside its core chemical distribution, adds a unique but minor revenue diversification.

Revenue Profitability And Efficiency

Tohoku Chemical reported revenue of ¥32.2 billion for the period, with net income of ¥237 million, reflecting thin margins typical of trading companies. Operating cash flow was negative at ¥-1.04 billion, likely due to working capital pressures, while capital expenditures remained minimal at ¥-64 million. The company’s asset-light model emphasizes distribution efficiency, but profitability is constrained by competitive pricing and operational costs.

Earnings Power And Capital Efficiency

The company’s diluted EPS was negligible, indicating limited earnings power relative to its revenue base. Capital efficiency appears modest, with no significant investments in production assets. Its reliance on trading margins and technical services suggests steady but low-return operations, typical of intermediaries in the chemical distribution sector.

Balance Sheet And Financial Health

Tohoku Chemical maintains a conservative balance sheet, with ¥764 million in cash and equivalents against ¥783 million in total debt, indicating near-neutral liquidity. The absence of excessive leverage aligns with its low-risk trading model, though the negative operating cash flow warrants monitoring for sustained working capital needs.

Growth Trends And Dividend Policy

Growth trends appear muted, with no explicit guidance on expansion. The company pays a dividend of ¥105 per share, signaling a commitment to shareholder returns despite modest earnings. Its focus on stable, niche markets limits cyclical exposure but also caps high-growth opportunities.

Valuation And Market Expectations

With a market cap of ¥3.5 billion and a beta of 0.21, the stock is priced as a low-volatility, small-cap niche player. The absence of significant earnings or growth catalysts suggests market expectations remain subdued, reflecting its regional and industry-specific constraints.

Strategic Advantages And Outlook

Tohoku Chemical’s strengths lie in its diversified product range and entrenched regional relationships. However, its outlook is tempered by limited scalability and reliance on Japan’s stagnant industrial demand. Strategic shifts toward higher-margin services or international expansion could enhance long-term prospects, but execution risks persist.

Sources

Company description, financial data from disclosed filings (FY ending 2024-09-30), and market data from exchange sources.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount